Table 2.
Comparison of general characteristics in first wave and second wave. Missing values were excluded from calculations.
| 1-st wave |
2-nd wave |
p-value | |||||
|---|---|---|---|---|---|---|---|
| N = 155 | N = 117 | ||||||
| Gender | M | n % | 101 | 65.2% | 70 | 59.8% | 0.3779 |
| Age | years | median IQR | 70.0 | 61–78 | 71.0 | 63–78 | 0.3436 |
| Albumin | g/dl | mean sd | 3.2 | 0.5 | 3.4 | 0.5 | 0.0024 |
| PCR | mg/dl | mean sd | 10.2 | 9.4 | 8.9 | 9.2 | 0.1951 |
| Heart diseases | yes | n % | 35 | 22.7% | 37 | 33.0% | 0.0699 |
| Hypertension | yes | n % | 87 | 56.5% | 70 | 62.5% | 0.3770 |
| Cerebrovascular diseases | yes | n % | 14 | 9.1% | 7 | 6.3% | 0.4925 |
| Diabetes | yes | n % | 31 | 20.1% | 30 | 26.8% | 0.2377 |
| Dyslipidemia | yes | n % | 42 | 27.3% | 28 | 25.0% | 0.7781 |
| COPD | yes | n % | 19 | 12.3% | 12 | 10.7% | 0.8469 |
| Asthma | yes | n % | 4 | 2.6% | 3 | 2.7% | 1.0000 |
| CKD | yes | n % | 21 | 13.6% | 16 | 14.3% | 1.0000 |
| Cancer | yes | n % | 24 | 15.5% | 35 | 29.9% | 0.0049 |
| Endocrinopathies | yes | n % | 13 | 8.4% | 11 | 9.4% | 0.8306 |
| SMA | cm2 | mean sd | 75.0 | 26.4 | 107.6 | 35.1 | 0.0000 |
| Sarcopenia | yes | n % | 88 | 57.9% | 25 | 21.6% | 0.0000 |
| Steatosis | yes | n % | 97 | 73.5% | 85 | 73.3% | 1.0000 |
| LOS | days | mean sd | 25.5 | 19.5 | 28.4 | 23.1 | 0.3033 |
| ICU admission | yes | n % | 39 | 25.2% | 38 | 32.5% | 0.2212 |
| Death | yes | n % | 23 | 14.8% | 31 | 26.5% | 0.0211 |
| ICU admission + Death | yes | n % | 54 | 34.8% | 54 | 46.2% | 0.6193 |
Abbreviations: M: male, n: number, SD: standard deviation, IQR: interquartile range, PCR: c-reactive protein, COPD: chronic obstructive pulmonary disease, CKD: Chronic Kidney Disease, SMA: skeletal muscle area, LOS: length of stay, ICU: intensive care unit.
Bold characters are used to stressed significant data.